Nabumetone 

Nabumetone
Systematic (IUPAC) name
4-(6-methoxy-2-naphthyl)-2-butanone
Identifiers
CAS number 42924-53-8
ATC code M01AX01
PubChem 4409
DrugBank APRD01128
Chemical data
Formula C15H16O2 
Mol. mass 228.29 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding > 99% (active metabolite)
Metabolism Hepatic, to active metabolite 6-methoxy-2-naphthylacetic acid
Half life 23 hours (active metabolite)
Excretion Renal
Therapeutic considerations
Pregnancy cat.

?

Legal status

POM

Routes Oral

Nabumetone is a non-steroidal anti-inflammatory drug1 of the arylalkanoic acid family (which includes diclofenac). It is available under numerous brand names, such as Relafen, Relifex and Gambaran.

It is used to treat pain or inflammation caused by arthritis. Nabumetone works by reducing the effects of hormones that cause pain and inflammation.

It has been shown to have a slightly lower risk of gastrointestinal side effects than most other non-selective NSAID's.

References

  1. ^ Gonzalo-Garijo MA, Cordobés-Duran C, Lamilla-Yerga AM, Moreno-Gastón I (2007). "Severe immediate reaction to nabumetone". Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología 17 (4): 274–6. PMID 17694703. 
Tablets  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.